The proposed study is a randomized clinical trial comparing the effects of enhanced medical therapy vs. hysterectomy on functioning and well-being in premenopausal women with abnormal uterine bleeding who do not respond adequately after three months of initial medical management. A second randomized trial will compare the effects of supracervical vs. total hysterectomy on function and well-being in women who undergo abdominal hysterectomy. Group differences in quality-of-life, clinical, sexual function, and economic outcomes will be examined. Four clinical centers will recruit and screen approximately 3000 premenopausal women, over age 30 with abnormal uterine bleeding, over a two-year period. For this study, abnormal bleeding is defined as more than eight days of menstrual flow per month or anemia (hematocrit <32 percent) in women with heavy flow and no other cause for anemia. Criteria for exclusion include: pregnancy, genital tract or breast malignancy, other indications for hysterectomy or adnexal removal, contraindications to progestins, oral contraceptive pills, or prostaglandin inhibitors, inability to comply with medical regimen or study follow-up, GnRH agonist therapy within 6 months of study entry, and rapid uterine enlargement (doubling over 6 months). Initially, three months of traditional progestin therapy will be administered. Several assumptions are then made to arrive at a sample size of 300 patients, who will be randomized to either medical therapy (oral contraceptive pills and prostaglandin inhibitors) or hysterectomy (abdominal or vaginal, based on clinical judgment of the gynecologist in consultation with the woman). For those patients scheduled to undergo abdominal hysterectomy, a second level of randomization will take place to have either a supracervical or a total hysterectomy. Patients will be followed for two years.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HS009478-05
Application #
6185569
Study Section
Special Emphasis Panel (ZHS1-HSRD-A (05))
Program Officer
Hubbard, Henrietta
Project Start
1996-09-30
Project End
2003-09-29
Budget Start
2000-09-30
Budget End
2003-09-29
Support Year
5
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Public Health & Prev Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Chao, Maria T; Abercrombie, Priscilla D; Nakagawa, Sanae et al. (2015) Prevalence and use of complementary health approaches among women with chronic pelvic pain in a prospective cohort study. Pain Med 16:328-40
Singh, Jaspreet K; Learman, Lee A; Nakagawa, Sanae et al. (2014) Sleep problems among women with noncancerous gynecologic conditions. J Psychosom Obstet Gynaecol 35:29-35
Diaz, O Vanessa; Guendelman, Sylvia; Kuppermann, Miriam (2014) Subjective social status and depression symptoms: a prospective study of women with noncancerous pelvic problems. Womens Health Issues 24:649-55
Jacoby, Vanessa L; Jacoby, Alison; Learman, Lee A et al. (2014) Use of medical, surgical and complementary treatments among women with fibroids. Eur J Obstet Gynecol Reprod Biol 182:220-5
Kuppermann, Miriam; Learman, Lee A; Schembri, Michael et al. (2013) Contributions of hysterectomy and uterus-preserving surgery to health-related quality of life. Obstet Gynecol 122:15-25
Learman, Lee A; Nakagawa, Sanae; Gregorich, Steven E et al. (2011) Success of uterus-preserving treatments for abnormal uterine bleeding, chronic pelvic pain, and symptomatic fibroids: age and bridges to menopause. Am J Obstet Gynecol 204:272.e1-7
Learman, Lee A; Gregorich, Steven E; Schembri, Michael et al. (2011) Symptom resolution after hysterectomy and alternative treatments for chronic pelvic pain: does depression make a difference? Am J Obstet Gynecol 204:269.e1-9
Kuppermann, Miriam; Learman, Lee A; Schembri, Michael et al. (2010) Predictors of hysterectomy use and satisfaction. Obstet Gynecol 115:543-51